Welcome to our dedicated page for Eastgate Biotech news (Ticker: ETBI), a resource for investors and traders seeking the latest updates and insights on Eastgate Biotech stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Eastgate Biotech's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Eastgate Biotech's position in the market.
EastGate Biotech (ETBI) has entered a three-way international distribution agreement with ImmunoJuvenate and Vedic Research Laboratories. This partnership will enable the marketing of a range of natural and ayurvedic products, starting with immunity-boosting items, across multiple regions, including North America and Europe.
ImmunoJuvenate plans to leverage social media and sales teams to promote these products, while EastGate aims to enhance its R&D efforts using revenue generated from this initiative. The collaboration highlights a commitment to improving health outcomes with innovative products.
EastGate Biotech Corp. has entered into a licensing and distribution agreement with Stenergy LLC and Butero Farms for their nutraceutical product, Glucora. The agreement includes a $3 million USD licensing fee, payable in cash and sales-driven funds. This partnership aims to leverage the growing e-commerce trend and consumer interest in health products. The distribution will cover the U.S., Canada, Central and South America, utilizing online and traditional retail channels. Butero Farms will supply the main ingredient, Banaba Leaf extract, ensuring uninterrupted production.
FAQ
What is the current stock price of Eastgate Biotech (ETBI)?
What is the market cap of Eastgate Biotech (ETBI)?
